Navamedic ASA: Q2 and first half 2019 financial results
Oslo, 23 August 2019 – Navamedic ASA (OSE: NAVA) continues to grow and reported revenues of NOK 47.2 million in the second quarter of 2019, up 4.4% from the same period in 2018. The company’s EBITDA came in at NOK 0.9 million (NOK 5.6 million in the second quarter of 2018), mainly due to project costs related to the demerger of Medtech, and increased focus on business development. The demerger and separate listing provide a platform for accelerated growth in both Pharma and Medtech. “We have initiated the implementation of the new growth strategy and see a great potential in leveraging